VanEck's TDIV ETF nears 52-week high as earnings season, ECB rate decision, and US GDP data loom. Top holdings like Verizon and Roche report, with financials and energy in focus.

Nestlé confirms Blue Bottle Coffee sale for under $400M, half its 2017 price, as Q1 organic sales growth of 3.5% beats ...

The stars are not aligning for Barrick Mining. While the Canadian gold giant posted a near-$5 billion profit last year and ...

The investment case for hydrogen has long been framed around decarbonisation. That story is being rewritten. Rising ...

German defence sensor maker Hensoldt sees orders surge 62% but shares near 52-week lows amid Chinese export restrictions and capacity expansion costs.

BioNTech's personalized mRNA cancer vaccine posts striking 6-year survival data in pancreatic cancer, while its CureVac subsidiary files a new patent lawsuit against Moderna.

ServiceNow shares rebound after 18% rout, driven by strong Q1 revenue and AI traction, but Armis acquisition margins and 39% ...

Oracle's $553B backlog and 84% cloud growth clash with $124.7B debt and negative cash flow, as stock trades 48% below its ...

Tesla launches Cortex 2 AI cluster in Texas but shares slide on $25B capex plan. Robotaxi service debuts in Dallas and Houston, yet expansion lags rivals like Waymo.

The week leading up to The Trade Desk’s first-quarter earnings release on May 7 has become a crucible for the ad-tech company, where a groundbreaking product la ...

ASX suspends European Lithium shares at A$0.285 after media reports of a potential change of control, with the Wolfsberg lithium project in Austria at the center of the story.

Frankfurt's DAX closed Friday at 24,129 points, dragged by defence sell-off and weak Ifo data, while SAP surged on strong cloud earnings.